Creating new methods to produce complex natural molecules for treating diseases
New Bond Disconnections in the Streamlined Synthesis of Complex Bioactive Molecules
This study is working on finding easier ways to make natural compounds from certain plants that could help treat diseases like cancer and HIV, with the hope that these new treatments will be available for patients in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-11012210 on NIH RePORTER |
What this research studies
This research focuses on developing innovative synthetic methods to create complex natural molecules that have potential therapeutic benefits for diseases such as cancer and HIV. By simplifying the chemical processes involved, the researchers aim to produce these biologically important compounds more efficiently and in larger quantities. The approach involves using natural products from specific plant families and applying new strategies to generate diverse chemical structures that can be tested for their medicinal properties. Patients may benefit from new treatments derived from these compounds as they progress through clinical trials.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by cancer, HIV, or neurodegenerative disorders.
Not a fit: Patients with conditions unrelated to cancer, HIV, or neurodegenerative diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective therapies for cancer, HIV, and neurodegenerative diseases.
How similar studies have performed: Previous research has shown success in developing therapeutic agents from complex natural products, indicating a promising avenue for this approach.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Maimone, Thomas John — University of California Berkeley
- Study coordinator: Maimone, Thomas John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.